Professor Simon Heller awarded prestigious NIHR senior investigator status
Professor Simon Heller, Director of Research and Development and Honorary Consultant Physician at Sheffield Teaching Hospitals Foundation Trust, has been reappointed as an NIHR Senior Investigator in recognition of his outstanding contribution to diabetes research.
The distinguished title is bestowed to some of the country’s foremost researchers, and was awarded after a rigorous open competition.
Professor Simon Heller’s research has played a major role in helping to advance the understanding and management of diabetes – a complex lifelong condition that can lead to damage to the eyes, feet, kidneys, hospital admissions and even premature death.
He is one of only 202 researchers across the UK to hold the honour.
Key research includes the potential contribution and mechanisms of low blood sugar levels which occur as a side effect of treatment, the use of insulin analogues and other technologies to treat diabetes more effectively, and the development and evaluation of tailored educational courses (including the DAFNE programme) to help people with diabetes manage their condition more effectively.
Professor Simon Heller, Director of Research and Development and Honorary Consultant Physician at Sheffield Teaching Hospitals Foundation Trust, said: “I am absolutely delighted to have received this prestigious honour for a second term. Shedding new light on diabetes is vital if we are to further understand the complex mechanisms by which the disease works and develop new drugs and treatments to manage it more effectively. This award is a welcome boost to research in the field, and I will use the funding to appoint new researchers and extend our research ideas.”
All candidates were judged by an independent expert panel chaired by Professor Melanie Davies, an Honorary Consultant Diabetologist at the University Hospitals of Leicester NHS Trust.
Criteria included: the quality and volume of internationally excellent research; its relevance to patients; the public; impact on improvements in healthcare and public health; research leadership; contribution to the NIHR; engagement of patients and the public and engagement of healthcare policy makers and planners with their research.